Drug Channels Institute (DCI) is a leading provider of industry research and educational solutions focused on pharmaceutical economics and the drug distribution system. With state-of-the-art instructional design and extensive industry knowledge, DCI delivers rigorous e-learning modules and industry reports that enhance the business acumen of employees at all levels.
DCI's comprehensive reports, such as the 2023 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers, provide a deep understanding of the complex interactions within the U.S. prescription distribution and reimbursement system. Through their engaging and accessible approach, DCI equips clients with accurate, fact-based content reflecting the latest developments in the pharmaceutical industry.
Generated from the website